Dermatology, Treatment Progression and Prior Authorization
Featuring a conversation between Denise Balch, President, Connex Health and Dr. Neil Shear, recently retired Dermatologist and Professor Emeritus, Temerty Faculty of Medicine: Dermatology, Clinical Pharmacology & Toxicology.
Challenges and New Solutions in the Prior Authorization Landscape
On April 19th and May 3rd, 2022, the Simplify Prior Authorization (SPA) initiative hosted webinars for patient groups and advisors/plan sponsors on the Challenges and New Solutions in the Private Prior Authorization Landscape.
The Need for Administrative Efficiencies in Prior Authorization
Featuring a conversation between Denise Balch, President, Connex Health and Ramy El-Kholi, Pharm.D., Chief Commercial Officer, OkRx.
The Rough Road to Navigating Drug Access in Canada
Featuring a conversation between Denise Balch, President, Connex Health and Alan Birch, the Associate Director, Provider Solutions – Oncology with Sentrex. Alan is also the founder of Drug Access Canada.
Addressing the Backlog of Cancer Patients
Canadians with cancer have been experiencing longer times to diagnosis and medical treatment during the pandemic. A backlog has been building that will take years to address, according to Dr Tony Eskander, surgical oncologist of the mouth, throat and neck at Sunnybrook Health Sciences Centre in Toronto.
Working Towards New Solutions in Prior Authorization
Since the release of the Simplify Prior Authorization white paper, we’ve been working with our sponsors, a new steering committee and working groups to help create a better understanding of the challenges of prior authorization and work towards a better process for patients and other stakeholders.
Why Prior Authorization is Important to Physicians
Featuring a conversation with Dr. Imtiaz Khan, Rheumatologist, practicing in Mississauga and Chair of the Ontario Rheumatologists Association Private Payers Committee.
Prior Authorization – The Future for Insurers and Pharmacy Benefit Managers (PBMs)
Prior authorization is typically used by insurers as a manual claim submission and review process for high-cost speciality or high-utilization prescription drugs.
Prior Authorization and Oncology
Featuring a conversation with Dr. Mark David Vincent, MB, ChB, MRCP(UK), FRCPC, Medical Oncologist, London Regional Cancer Program.
Prior Authorization and the Impact on Physicians
During research for the Simplify Prior Authorization (SPA) white paper in 2020, we learned how the prior authorization (PA) workflow process was impacting prescribers.
